- Report
- July 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- December 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- December 2024
- 150 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- November 2024
- 120 Pages
Latin America
From €5656EUR$5,950USD£4,752GBP
- Report
- November 2024
- 91 Pages
Europe
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2023
- 150 Pages
Global
From €2139EUR$2,250USD£1,797GBP
€4278EUR$4,500USD£3,594GBP
- Report
- November 2019
- 41 Pages
Germany
- Report
- August 2020
- 139 Pages
Global
From €1307EUR$1,375USD£1,098GBP
€2614EUR$2,750USD£2,196GBP
- Report
- December 2021
- 200 Pages
Global
From €2282EUR$2,400USD£1,917GBP
- Report
- July 2022
- 150 Pages
Global
From €2139EUR$2,250USD£1,797GBP
- Report
- December 2020
- 64 Pages
United States
From €808EUR$850USD£679GBP
- Report
- November 2020
- 82 Pages
North America
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2022
- 37 Pages
United States
- Report
- January 2022
- 14 Pages
Europe
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 395 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- August 2022
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- August 2022
- 115 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Clinical Trials
- February 2024
- 60 Pages
Global
From €1188EUR$1,250USD£998GBP

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease.
CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions.
The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more